24 March 2017 Volume 24 Supplement 1 S1 Volume 24 Volume Supplement 1 P ages AX–AXX ages EUROPEAN JOURNAL OF HOSPITAL PHARMACY OF HOSPITAL JOURNAL EUROPEAN ABSTRACT BOOK 22nd EAHP Congress 22–24 March 2017 Cannes, France March 2017 March CALL FOR ABSTRACTS - 2018 GOTHENBURG 23rd Congress of the EAHP, 21st - 23rd March 2018, Gothenburg, Sweden Abstract submission opens 1st August, 2017! Original contributions from all felds of hospital pharmacy are encouraged and welcomed for poster presentation. Deadline for submission: 15th October 2017 During the review process, the award nominees will be selected and the presenting author of the nominated abstracts will be invited to give an oral presentation after which the fnal judging will take place. Please be sure to provide an email address which will not be blocked by spam servers so that EAHP may notify you for modifcations and nominations. (Abstracts may be submitted through the EAHP web site’s online submission page.) IMPORTANT NOTE: The online submission form does not recognise some symbols from certain keyboards. Therefore, please proof your abstract after it has been entered into the system and before your fnal submission. Please visit the EAHP web site at http://www.eahp.eu/congresses/abstract to view the guidelines and to submit abstracts for the Gothenburg congress 2018. Abstracts must be entered into the system by section according to the guidelines. There will be 5 sections: Background - Purpose - Material and methods - Results - Conclusion Contents Volume 24 Supplement 1 | EJHP March 2017 Abstracts from the EAHP 2017 Congress A1 Clinical pharmacy A179 Other hospital pharmacy topics A109 Drug distribution A193 Pharmacokinetics and pharmacodynamics A113 Drug information and pharmacotherapy A202 Production and preparation A158 General management A227 Patient safety and risk management A173 International posters POSTER AWARD NOMINEES Presentations on Wednesday, 22 March, 14:00 – 15:00, Auditorium I Time Poster number Poster nominee oral presentations Author 14:00 PP-001 Hypromellose prolongs the dissolution of ketamine Länger, Ursula out of gelatine capsules 14:10 PP-003 Stability study of bortezomib (velcade) with limit test Nissen, Klaus Bertram for all degradation products 14:20 PP-014 Stability study of 10 mg/ml paediatric cyclosporine Mortier, Charles-Patrick solution in olive oil 14:30 PP-029 Stability of frozen 1% voriconazole eye drops in glass Roche, Marine and in innovative containers 14:40 PS-029 Feasibility of utilisation and patient satisfaction with a Ulmer, Inga nationwide standardised electronic medication plan 14:50 PS-038 Developing a method for identifying a university Tyynismaa, Lotta hospital’s high alert medications Presentations on Thursday, 23 March, 09:00 – 10:00, Auditorium I Time Poster number Poster nominee oral presentations Author 09:00 CP-086 CD69 A>G (rs11052877) genetic polymorphism on Díaz-Villamarín, Xando the response to tocilizumab in rheumatoid arthritis patients 09:10 CP-109 Evaluation of clinical, economic and organisational Duwez, Marion impacts of pharmacists’ interventions on immunosuppressive therapy management among lung transplant outpatients 09:20 CP-116 Evaluation of the clinical signifcance and value of a Mueller, Dora clinical pharmacy service at a teaching hospital 09:30 DI-052 Developing an interactive tool to educate patients on Gschwind, Liliane good management of drugs 09:40 PKP-003 Infuence of cytarabine metabolic pathway Megías-Vericat, Juan polymorphisms in effectiveness of acute myeloid Eduardo leukaemia induction treatment 09:50 PKP-009 Relation between clinical remission and trough Cordelle, Claire infiximab levels in children with infammatory bowel disease A invites ou to attend the neg nteactive ession Anticoagulants - show me the evidence supported by an educational grant from Bayer Wednesday, 22 March 2017 - 2:00pm to 3:30pm Thursday, 23 March 2017 - 9:00am to 10:30am Auditorium K FACILITATOR KORNELIA CHRAPKOVA SOTIRIS ANTONIOU MEDICINES OPTIMISATION – IMPROVING ANTICOAGULATION GLOBALLY – INTRODUCTION CRAIG COLEMAN THE IMPORTANCE OF ADHERENCE TO NON-VKA ORAL ANTICOAGULANTS IN NONVALVULAR ATRIAL FIBRILLATION FILIPA COSTA OPTIMISING ADHERENCE IN ATRIAL FIBRILLATION HELEN WILLIAMS ADDRESSING UNMET NEEDS IN MANAGING AF ACROSS THE GLOBE PRESENTERS ACPE UAN: 0475-0000-17-005-L04-P. An application based activity. The European Association of Hospital Pharmacists (EAHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education EAHP invitEs you to AttEnd tHE 2017 synErgy sAtEllitE EvEnt 10 YEARS OF BIOSIMILARS WHAT HAVE WE LEARNED? supported by an educational grant from amgen Wednesday, 22 March 2017 - 11:30am to 1:00pm Théâtre Claude Debussy FACILITATOR TORSTEN HOPPE-TICHY PAUL DECLERCK The European Biosimilar Quality Experience IRENE KRÄMER Naming, tracing, switching and other safety issues after 10 years learning PAUL CORNES 10 years of biosimilars - who benefts? PRESENTERS ACPE UAN: 0475-0000-17-004-L04-P. A knowledge based activity. The European Association of Hospital Pharmacists (EAHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education Abstracts Clinical pharmacy CP-002 WITHDRAWN CP-001 WITHDRAWN Eur J Hosp Pharm 2017;24(Suppl 1):A1–A288 A1 Abstracts CP-003 WITHDRAWN CP-004 A REVIEW OF URINARY TRACT INFECTION MANAGEMENT FOR PATIENTS ADMITTED TO THE EMERGENCY DEPARTMENT: ASSESSMENT OF ADHERENCE TO GUIDELINES AND IDENTIFICATION OF HOSPITALISATION CRITERIA 1A Ramdani*, 2S Rebaudet, 3NBeni-chougrane,4GPenaranda,1ECoquet.1Hôpital Européen, Pharmacy Department, Marseille, France; 2Hôpital Européen, Infectious Diseases Department, Marseille, France; 3Hôpital Européen, Sanitary Department, Marseille, France; 4Alphabio, Biostatistics Department, Marseille, France 10.1136/ejhpharm-2017-000640.4 Background Community acquired urinary tract infection (UTI) is one of the most common indications for antibiotic prescription. Previous studies on adherence to guidelines on antibiotic use reported a prevalence of inappropriate prescriptions varying from 20% to 50%, in both community and hospital settings. The misuse of antibiotics not only has an important economic impact but can also lead to therapeutic impasses. Purpose This study aimed to establish the current management of UTIs in patients admitted to the emergency department (ED) of our hospital. Material and methods In this retrospective observational study conducted between January 2015 and May 2016, consecutive patients admitted to the ED for a suspected UTI were assessed, including patients hospitalised (n=50) or discharged (n=50) after their ED admission. Assessment of adherence to guidelines for antibiotic prescription was conducted using the guidelines of the French Speaking Society of Infectious Disease (SPILF). Results In the hospitalised group, 22 (44%) antibiotic prescrip- tions initiated at the ED did not comply with national guide- lines. The two main causes for inappropriate prescriptions were the use of two antibiotics in patients with no severity criteria (15.68%) and/or the use of a non-recommended drug (6.27%). In this group, 17 (35%) antibiotic prescriptions ordered by the urologist on patient discharge did not comply with national guidelines. The two main causes of inappropri- ate prescriptions were the use of a non-recommended drug (9.53%) and an inadequate duration of treatment (9.53%). In the discharged group, 29 (60%) of the antibiotic pre- scriptions ordered at the ED did not comply with national guidelines. The two main causes of inappropriate prescriptions were an inadequate duration of treatment (23.79%) and the use of a non-recommended drug (19.66%). We also identified discrepancies between reasons for hospi- talisation in our cohort compared with the criteria for hospi- talisation mentioned in the national guidelines. Conclusion This study has identified areas for improvement in the management of UTIs in our hospital. Our suggestions for optimisation include educational materials and a decision tree displayed in the ED, and specific therapeutic protocols in our computerised prescription system. REFERENCES AND/OR ACKNOWLEDGEMENTS SPILF Guidelines 2015: http://www.infectiologie.com/fr/recommandations.html No conflict of interest A2 Eur J Hosp Pharm 2017;24(Suppl 1):A1–A288 Abstracts CP-005 WITHDRAWN CP-007 MEDICATION ERRORS IN VOLUNTARY REPORTED INCIDENTS AT A UNIVERSITY HOSPITAL 1KAbuHamour*,2M Abdel Jalil. 1Jordan University Hospital, Amman, Jordan; 2University of Jordan, Biopharmaceutics and Clinical Pharmacy, Amman, Jordan 10.1136/ejhpharm-2017-000640.7 Background A significant yet preventable cause of inpatient and outpatient morbidity and mortality is medication errors. Appropriate error reporting systems are the cornerstone of any plan designed to enhance patient safety.1 Purpose The aim of the study was to assess the prevalence, origin, type and severity of reported medication incidents at a university hospital, utilising a voluntary non-punitive reporting system. Material and methods The present study had a retrospective design. All voluntary non-punitive incident reports that occurred between January 2014 and March 2015 at the hos- pital were retrieved from the quality department. Detailed CP-006 WITHDRAWN content analysis was conducted to obtain all relevant informa- tion. Data were coded anonymously and analysed using SPSS version 20. Results There was an increase in reporting of medication errors over time, and almost